News
A new US consensus clarifies chronic hand eczema (CHE) diagnosis and stepwise care, highlighting FDA-approved treatment and patient-reported outcomes.
Chronic spontaneous urticaria (CSU) is being redefined thanks to advances in disease understanding and an expanding therapeutic landscape, said Adam Friedman, MD, FAAD, Chair of Dermatology at The George Washington University School of Medicine & Health Science in Washington, DC, at the 2026…
Vishal A. Patel, MD, shares skin cancer prevention tips, highlighting sun-smart habits, risk-based screening, and at-home early detection.
Positive results have been released from the 36-week blinded maintenance period of the 52-week REZOLVE-AD study of rezpegaldesleukin, a novel regulatory T-cell (Treg) biologic, in individuals with moderate-to-severe atopic dermatitis.1
These data, announced on February 10 by Nektar…
Nektar Therapeutics (NKTR) Discusses 36-Week Maintenance Results From Phase 2b REZOLVE-AD Study in Atopic Dermatitis February 10, 2026 8:00 AM EST
This staple ingredient may not be the cure-all some claim it is, but there are plenty of ways it can benefit your skin and hair.
Itchy armpits are a common nuisance. Dermatologists explain the potential causes of underarm itching and when to see a doctor.
Doctors warn viral off-label use lacks evidence, with unknown long-term risks and possible systemic absorption
Having just returned from the American Academy of Dermatology Annual Meeting, Dr Adam Friedman comments on a rapidly evolving landscape for chronic spontaneous urticaria (CSU), moving beyond antihistamines to redefine disease management. Promising new therapeutics were presented, including…
Experts explore innovative treatments for pediatric atopic dermatitis, emphasizing non-steroidal options and early intervention for better long-term management.
